The Regenesis Project Investigates a New Treatment Possibility for Dementia, Alzheimer’s and Parkinson’s Disease
A recent study from The Regenesis Project demonstrates bosutinib may be a treatment option for patients with neurodegenerative conditions including Alzheimer’s and Parkinson’s disease. SANTA MONICA, Calif., Oct. 6, 2020 /PRNewswire/ — The pursuit of an effective therapeutic intervention for dementia has inspired interest in the class of medications known as tyrosine kinase inhibitors (TKIs). TKIs demonstrate potential… Read More